• About
  • Meet The Team
  • Privacy Policy
Monday, January 25, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

Don’t Miss these 15 Biotechnology Value Stocks

by Shan Zee
December 11, 2020
in Featured
Share on FacebookShare on Twitter

Biotech and Major Pharmaceuticals are back in the news with the Covid-19 Pandemic. Life science investors basically endorse developments that might decide the human race’s future, but what would invest in ‘cures’ mean from a cash flow point of view?
On Thursday, a panel of independent health professionals voted 17-4 in support of the Food and Drug Administration(FDA), providing emergency permission to the applicant for the COVID-19 vaccine from BioNTech and Pfizer Inc.
In other news Gilead Sciences Inc (GILD) revealed that it would buy MYR GmbH in cash for roughly EUR 1.15 billion ($1.39 billion), granting it access to the German biotech company’s therapy for extreme viral hepatitis.
In yesterday’s trading session, the following stocks were the major key players.

Immutep Limited (NASDAQ:IMMP) shares were trading up 163.43% at $5.69 at the time of writing on Thursday after declaring that its Chinese partner, EOC Pharma will commence a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China.

Immutep Limited (NASDAQ:IMMP) share price went from a low point around $0.53 to briefly over $3.10 in past 52 weeks, though shares have since pulled back to $5.69. IMMP market cap has remained high, hitting $280.46M at the time of writing.

If we look at the recent analyst rating IMMP, B. Riley FBR initiated coverage on IMMP shares with a Buy rating.

TG Therapeutics Inc. (TGTX) stock soar by 40.85% to $41.72 after reportingpositive topline results from the ULTIMATE I & II Phase 3 studies evaluating Ublituximab Monotherapy for the treatment of patients with multiple sclerosis. The most recent rating by JP Morgan, on September 01, 2020, is at an Overweight.

Heat Biologics Inc. (HTBX) last closed at $0.93, in a 52-week range of $0.19 to $4.30.

Sangamo Therapeutics Inc. (NASDAQ:SGMO) Shares headed rising, higher as much as 52.98%. Pfizer Inc. (PFE) and Sangamo Therapeutics, Inc. (SGMO), on December 7, 2020 declared updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec (SB-525 or PF-07055480), an investigational gene therapy for patients with severe hemophilia A. The most recent rating by BofA Securities, on September 08, 2020, is at a Buy.

Entera Bio Ltd. (NASDAQ:ENTX) rose 8.18% after gaining more than $0.09 on Thursday following the firm revealed FDA approval of IND application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the treatment of Osteoporosis.

Aytu BioScience Inc. (AYTU) last closed at $8.13, in a 52-week range of $3.35 to $29.90 after announcing definitive merger agreement with Neos Therapeutics, creating a combined $100M revenuespecialty pharmaceutical company.

Amarin Corporation plc (AMRN) stock soar by 8.04% to $4.97. The most recent rating by JP Morgan, on September 29, 2020, is at a Neutral.

Editas Medicine Inc. (NASDAQ:EDIT) Shares headed rising, higher as much as 32.15% following an announcement from the company that it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1/2 clinical trial of EDIT-301. The most recent rating by Wells Fargo, on December 10, 2020, is at an Overweight.

Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) rose 9.04% after gaining more than $0.15 on Thursday.

Akebia Therapeutics Inc. (AKBA) last closed at $2.95, in a 52-week range of $2.09 to $13.71. The firm recently revealed the latest scheduled program of AkebiaShares, a peer-to-peer educational series for the kidney community.

BioCryst Pharmaceuticals Inc. (BCRX) stock soar by 5.37% to $7.65. The company recently announced transactions with Royalty Pharma (RPRX) and Athyrium Capital Management, LP, totaling $325 million in funding for BioCryst, with $250 million available at closing, to support the launch of ORLADEYO™ (berotralstat) in hereditary angioedema (HAE) and the development of its oral Factor D inhibitor, BCX9930. The most recent rating by JP Morgan, on September 29, 2020, is at an Overweight.

Acasti Pharma Inc. (NASDAQ:ACST) Shares headed rising, higher as much as 1.70%. The company on November 16, 2020 released its operating and financial results for the second quarter of fiscal 2021 ended September 30, 2020. The most recent rating by Oppenheimer, on September 01, 2020, is at a Perform.

Ocugen Inc. (NASDAQ:OCGN) fall -1.79% after losing more than -$0.01 on Thursday after reporting that it will postpone its 2020 Annual Meeting of Stockholders to December 23, 2020.

Inovio Pharmaceuticals Inc. (INO) last closed at $11.36, in a 52-week range of $2.42 to $33.79. The firm recently revealedthe successful dosing of its first subject in its Phase 2 clinical trial for COVID-19 DNA vaccine candidate, INO-4800, in China. Analysts have a consensus price target of $13.71.

Cellectar Biosciences Inc. (CLRB) stock soar by 3.47% to $2.09. The most recent rating by Oppenheimer, on July 01, 2020, is at an Outperform.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: Acasti PharmaACSTAKBAAkebia TherapeuticsAmarinAMRNAYTUAytu BioScienceBCRXBioCryst PharmaceuticalsCellectar BiosciencesCLRBEDITEditas MedicineEntera BioENTXHeat BiologicsHEPAHepion PharmaceuticalsHTBXIMMPImmutep LimitedINOInovio PharmaceuticalsOCGNOcugenSangamo TherapeuticsSGMOTG TherapeuticsTGTX

Related Posts

Top 3 Transportation Stocks to Watch for in 2021
Featured

Top 3 Transportation Stocks to Watch for in 2021

January 25, 2021
iBio (IBIO) Announces Deal With Safi Biosolutions To Develop Cytokines And Growth Factors
Featured

3 of the Best Biotech Stocks to Buy for 2021

January 25, 2021
Featured

Top Cyclical Stocks to Watch For in 2021

January 23, 2021
Top Performers Markets Awaits News from Congress and the Federal Reserve
Featured

GameStop (GME) Stock Continues to Spike Days after the Appointment of Ryan Cohen

January 22, 2021
Top 3 Reasons Why AzurRx Biopharma Inc [AZRX] is Gaining Bullish Momentum
Featured

Fluidigm (FLDM) Stock Gives Green Signal as it obtains CE-IVD ‎Mark for Its COVID-19 Test

January 22, 2021
Tesla Inc (NASDAQ:TSLA) Stock Is Soaring. Here’s Why.
Featured

Jaguar Health (JAGX) Closes its $6M Promissory Notes, What’s Next for JAGX Stock?

January 21, 2021
Next Post

10 Stocks We Like in Gold Industry

Looking for $1 Stock? BIOLASE (BIOL) is a Decent Bet

by Ali Hassan
January 21, 2021
0

The dental device firm is bullish and looks solid for long-term growth. The medical device firm, BIOLASE Inc. (BIOL) had...

Read more

Early Morning Vibes: The 4 Best Stocks To Buy Now

9 Trending Stocks in Travel Services Industry That Can Be A Good Bets
by Shan Zee
January 20, 2021
0

On January 19, American stock indexes finished trading in the green zone. The S&P 500 Index rose 0.81% to 3799...

Read more

Early Morning Vibes: Top 4 Stocks To Watch Right Now

Why Tesla Inc (NASDAQ: TSLA) Stock Might Be A Great Pick?
by Shan Zee
January 19, 2021
0

For Martin Luther King Day, the U.S. treasuries were closed yesterday. In the meantime, on Wednesday, the Americans are waiting...

Read more

Early Morning Vibes: 4 Stocks We Like for Thursday

Energy Focus (NASDAQ: EFOI) Introduces Portfolio Of Germicidal UV-C Disinfection Products
by Hasnain R
January 21, 2021
0

On January 20, American stock markets closed at new all-time highs. The S&P 500 index rose 1.39% to 3852 points,...

Read more

GameStop (GME) Stock Continues to Spike Days after the Appointment of Ryan Cohen

Top Performers Markets Awaits News from Congress and the Federal Reserve
by Ali Hassan
January 22, 2021
0

Is the bull run going to end anytime soon, or should you invest in GME now? Investors are having a...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.